Pharmaceutical Product Pricing and Contracting
Our team is a leader in providing the full range of counseling, litigation and advocacy services on pharmaceutical pricing and contracting issues. We regularly provide advice, in-depth analyses and internal training on calculating the various pricing metrics that are reported to federal agencies or that set price ceilings (e.g., AMP, Best Price, Section 340B, ASP, non-FAMP, and federal ceiling price), and on related reporting and administrative requirements. We also represent clients in negotiating and advising on reporting requirements for Federal Supply Schedule (FSS) contracts. We represent companies in connection with litigation, internal investigations and government audits concerning pharmaceutical pricing issues and assist manufacturers in conducting reviews to evaluate the adequacy of existing compliance policies. Major manufacturers and a leading industry trade association rely on us for advice on the intersection of state and federal fraud and abuse laws with developing government pricing and reimbursement issues.
Unparalleled Knowledge of the Field: Our representation of an industry trade association on pricing and related legislative matters, combined with our work for a diverse range of individual companies, has given us a distinct, industry-wide perspective of the pharmaceutical-pricing landscape.
Thriving on Complexity: Our sophisticated practitioners have dealt with some of the most complex drug-pricing matters, including challenging investigations and litigations and novel value-based arrangements with payors.
Proactive Assistance: Our knowledge of developments in the field and benchmarking of industry practices gives our clients the ability to better gauge risk and avoid problems before they occur.